Show simple item record

dc.contributor.authorLucas, Beverley J.
dc.contributor.authorBlenkinsopp, Alison
dc.date.accessioned2016-05-17T13:48:00Z
dc.date.available2016-05-17T13:48:00Z
dc.date.issued2015-12
dc.identifier.citationLucas BJ and Blenkinsopp A (2015) Community pharmacists’ experience and perceptions of the New Medicines Service (NMS). International Journal of Pharmacy Practice. 23(6): 399-406.en_US
dc.identifier.urihttp://hdl.handle.net/10454/8364
dc.descriptionYesen_US
dc.description.abstractObjectives The New Medicines Service (NMS) is provided by community pharmacists in England to support patient adherence after the initiation of a new treatment. It is provided as part of the National Health Service (NHS) pharmacy contractual framework and involves a three-stage process: patient engagement, intervention and follow-up. The study aims to explore community pharmacists’ experiences and perceptions of NMS within one area of the United Kingdom. Methods In-depth semi-structured telephone interviews were conducted with 14 community pharmacists. Interviews were audio-recorded, independently transcribed and thematically analysed. Key findings Pharmacists gave a mixed response to the operationalisation, ranging from positive opportunities for improving adherence and enhancement of practice to difficulties in terms of its administration. Pharmacists generallywelcomed opportunities to utilise their professional expertise to achieve better patient engagement and for pharmacy practice to develop as a patient resource. There was a perceived need for better publicity about the service. Different levels of collaborative working were reported. Some pharmacists were working closely with local general practices most were not. Collaboration with nurses in the management of long-term conditions was rarely reported but desired by pharmacists. Where relationships with general practitioners (GPs) and nurses were established, NMS was an opportunity for further collaboration; however, others reported a lack of feedback and recognition of their role. Conclusions Community pharmacists perceived the NMS service as beneficial to patients by providing additional advice and reassurance, but perceptions of its operationalisation were mixed.Overall, our findings indicate that NMS provides an opportunity for patient benefit and the development of contemporary pharmacy practice, but better collaboration with GPs and practice nurses could enhance the service.en_US
dc.language.isoenen_US
dc.relation.isreferencedbyhttp://dx.doi.org/10.1111/ijpp.12180en_US
dc.rights© 2015 Wiley. This is the peer reviewed version of the following article: Lucas A and Blenkinsopp A (2015) Community pharmacists’ experience and perceptions of the New Medicines Service (NMS). International Journal of Pharmacy Practice, 23 (6): 399–406, which has been published in final form at http://dx.doi.org/10.1111/ijpp.12180. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
dc.subjectGeneral practitioners; Interprofessional collaboration; Pharmacists; Community pharmacists; Professional pharmacy services; Teamwork; New Medicines Service (NMS)en_US
dc.titleCommunity pharmacists’ experience and perceptions of the New Medicines Service (NMS)en_US
dc.status.refereedYesen_US
dc.date.Accepted2015-01-08
dc.date.application2015-02-25
dc.typeArticleen_US
dc.type.versionAccepted Manuscripten_US
refterms.dateFOA2018-07-25T13:58:00Z


Item file(s)

Thumbnail
Name:
onlineLibraryTPS.pdf
Size:
557.0Kb
Format:
PDF
Description:
Published version
Thumbnail
Name:
Lucas_&_Blenkinsopp_Int_Jnl_Ph ...
Size:
391.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record